Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70005 |
LY3325656
|
||
LY3325656 is a GPR142 agonist suitable for clinical testing in human. LY3325656 demonstrated anti-diabetic benefits in pre-clinical studies and ADME/PK properties suitable for human dosing. LY3325656 is the first GPR142 agonist molecule advancing to phase 1 clinic trials for the treatment of Type 2 diabetes. | |||
T70004 |
APS-2-79
|
||
APS-2-79 是一种 KSR 依赖性的MEK 拮抗剂。APS-2-79 与 ATPbiotin 竞争性地结合到 KSR2-MEK1 复合物内的KSR2,IC50为 120 nM。APS-2-79 与 KSR 结合可将 KSR 固定在一个非活性的状态,使其无法再结合RAF 和激活MEK,从而阻断了 Ras-MAPK 信号通路。 |